Retour à l'accueil - Logo MICAH

Microenvironnement et cancers hématologiques

Accueil > PUBLICATIONS > Publications du laboratoire

Publications du laboratoire


  • Maitre E, Tomowiak C, Lebecque B, Bijou F, Benabed K, Naguib D, Kerneves P, Cornet E, Viailly PJ, Arsham J, Sola B, Jardin F, Troussard X. Cancers 2022, 14: 1904. PMID: 35454811
  • Troussard X, Maître E, Cornet E. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. Am J Hematol 2022, 97: 226-236. PMID: 34710243


  • Paillassa J, Troussard X. Patients with relapsed/refractory hairy-cell leukemia. Cancer Rep 2021, 5: e1495. PMID: 34250762
  • Troussard X, Grever MR. The revised guidelines for the dignosis and management of hairy cell leukaemia and the hairy cell leukaemia variant. Br J Haematol 2021, 193: 11-14. PMID: 3368172
  • Wiber M, Maitre E, Poncet JM, Duchenet V, Damaj G, Cornet E, Troussard X. A population-based study of hairy cell leukemia over a period of 20 years. Cancer Treat Res Commun 2020, 25: 100236. PMID: 33227559
  • Caillot M, Dakik H, Mazurier F, Sola B.  Targeting reactive oxygen species metabolism to induce myeloma cell death. Cancers 2021, 13: 2411.


  • Quinquenel A, Aurran-Schleinitz T, Clavert A, Cymbalista F, Dartigeas C, Davi F, de Guibert S, Delmer A, Dilhuydy MS, Feugier P, Fornecker LM, Ghez D, Guieze R, Laribi K, Leblond V, Leprêtre S, Letestu R, Lévy V, Nguyen-Khac F, Michallet AS, Tomowiak C, Tournilhac O, Ysebaert L, Troussard X. Diagnosis and treatment of chronic lymphocytic leukemia: recommendations of the French CLL study group (FILO). Hemasphere 2020, 4: e473. PMID: 33062946
  • Caillot M, Zylbersztejn F, Maitre E, Bourgeais J, Hérault O, Sola B.  ROS overproduction sensitises myeloma cells to bortezomib-induced apoptosis and alleviates tumour-microenvironment-mediated cell resistance. Cells 2020, 9: 2357. doi: 10.3390/cells9112357
  • Miloudi H, Bohers E, Guillonneau F, Taly A, Cabaud Gibouin V, Viailly PJ, Jego G, Grumolato L, Jardin F, Sola B. XPO1E571K mutation modifies exportin 1 localisation and interactome in B-cell lymphoma. Cancers 2020, 12: 2829.  doi: 10.3390/cancers12102829
  • Caillot M, Bourgeais J, Dakik H, Costé É, Mazure NM, Lelièvre É, Coqueret O, Hérault O, Mazurier F, Sola B. Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells. Oncogenesis 2020, 9: 68. PMID: 3279889
  • Paillassa J, Cornet E, Noel S, Tomowiak C, Leprêtre S, Vaudaux S, Dupuis J, Devidas A, Joly B, Petitdidier-Lionnet C, Haiat S, Mariette C, Thieblemont C, Decaudin D, Validire-Charpy P, Drenou B, Eisenmann JC, Uribe MO, Olivrie A, Touati M, Lambotte O, Hermine O, Karsenti JM, Feugier P, Vaillant W, Gutnecht J, Lippert E, Huysman F, Ghomari K, Boubaya M, Levy V, Riou J, Damaj G, Tanguy-Schmidt A, Hunault-Berger M, Troussard X. Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up. Blood Cancer J 2020, 10: 62. PMID: 32461544
  • Roué G and Sola B. Management of drug resistance in mantle cell lymphoma. Cancers 2020, 12: 1565. PMID: 32545704
  • Gonzalez-Santamarta M, Quinet G, Reyes-Garau D, Sola B, Roué G, Rodriguez MS. Resistance to the proteasome inhibitors: lessons from multiple myeloma and mantle cell lymphoma. Adv Exp Med Biol 2020; 1233: 153‐174. PMID: 32274756
  • Tchakarska G, Sola B. The double dealing for cyclin D1. Cell Cycle 2020; 19: 163-293. PMID: 31885322


  • Maitre E, Cornet E, Troussard X. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. Am J Hematol 2019; 94: 1413-1422. PMID: 31591741
  • Maitre E, Troussard X. Monoclonal B-cell lymphocytosis. Best Pract Res Clin Haematol 2019; 32: 229-238. PMID: 31585623
  • Wiber M, Maitre E, Cornet E, Salaün V, Naguib D, Troussard X. Variant form of hairy cell leukemia. Clin Case Rep 2019; 7: 1161-1166. PMID: 31183086
  • Hueso T, Johnson-Ansah H, Decamp M, Maitre E, Henry A, Mensi S, Vilque JP, Chantepie S, Damaj G. Successful imatinib therapy as a bridge to transplant in an atypical myeloproliferative neoplasm. Curr Res Transl Med 2019; 67: 149-150. PMID : 31153956
  • Barré L, Hovhannisyan N, Bodet-Milin C, Kraber-Bodéré F, Damaj G. [18F]-Fludarabine for hematological malignancies. Front Med 2019; 6: 77. PMID : 31058154
  • Maitre E, Le-Page AL, Comoz F, Truquet F, Damaj G, Cornet E, Verneuil L, Salaün V, Troussard X.  Usefulness of flow cytometry for the detection of cutaneous localization in malignant hematologic disorders. Cytometry B Clin Cytom 2019; 96: 283-293. PMID: 31050147
  • Chantepie S, Yakoub-Agha I, Damaj G. Be ever cautious until the truth is proven. Am J Hematol 2019; 94: E106. PMID: 30663789


  • Maitre E, Bertrand P, Maingonnat C, Viailly PJ, Wiber M, Naguib N, Salaün V, Cornet E, Damaj G, Sola B, Jardin F, Troussard X. New generation sequencing of targeted genes in the classical and the variant forms of hairy cell leukemia highlights mutations in epigenetic regulation genes. Oncotarget 2018; 9: 28866-28876. PMID: 29989027
  • Chantepie SP, Garciaz S, Tchernonog E, Peyrade F, Larcher MV, Diouf M,Fornecker LM, Houot R, Gastinne T, Soussain C, Malak S, Lemal R, Delette C, Ibrahim A, Gac AC, Reboursière E, Vilque JP, Bekadja MA, Casasnovas RO, Gressin R, Guidez S, Coso D, Herbaux C, Yakoub-Agha I, Bouabdallah K, Durot E, Damaj G. Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers. Am J Hematol 2018; 93: 729-735. PMID: 29473209
  • Miloudi H, Leroy K, Jardin F, Sola B. STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma. Cell Signal 2018; 46: 76-82. PMID: 29501729
  • Solal-Céligny P, Leconte P, Bardet A, Hernandez J, Troussard X. A restrospective study on the management of patients with rituximab refractory follicular lymphoma. Br J Haematol 2018; 92: 1382-1390. PMID: 29230799
  • Body S, Esteve-Arenys A, Recasens-Zorzo C, Troussard X,  Roué G, Sola B. A mouse model of disseminated mantle cell lymphoma highlights a lack of activity of estrogen receptors β antagonists toward tumor burden. Leuk Lymphoma 2018; 59: 1726-1729. PMID: 29164964


  • Troussard X, Cornet E. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment. Am J Hematol. 2017; 92: 1382-1390. PMID: 29110361
  • Body S, Esteve-Arenys A, Miloudi H, Recasens-Zorzo C, Tchakarska G, Moros A, Bustany S, Vidal-Crespo A, Rodriguez V, Lavigne R, Com E, Casanova I, Mangues R, Weigert O, Sanjuan-Pla A, Menéndez P, Marcq B, Picquenot JM, Pérez-Galán P, Jardin F, Roué G, Sola B. Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells. Sci Rep 2017; 7: 13946. PMID: 29066743.
  • Ben Younes K, Body S, Costé E, Viailly PJ, Miloudi H, Coudre C, Jardin F, Ben Aissa-Fennira F, Sola B. A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress. BMC Cancer 2017; 17: 538. PIMD: 28797244
  • Damaj G, Benbrahim O, Hacini M, Voronina I, Benabed K, Soumoudronga RF, Gasnereau I, Haioun C, Solal-Céligny P. ZOHé: A prospective study of the use of biosimilar filgrastim Zarzio in clinical practice in patients treated with chemotherapy for lymphoid malignancies. Clin Lymphoma Myeloma Leuk 2017; 17: 362-369.e2. PMID: 28472196
  • Hovhannisyan N, Dhilly M, Fidalgo M, Fillesoye F, Guillouet S, Sola B, Barré L.  [18F]Fludarabine-PET in a murine model of multiple myeloma. PLoS One 2017; 12: e0177125. PMID: 28472196
  • Camus V, Miloudi H, Taly A, Sola B, Jardin F. XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy. J Hematol Oncol 2017; 10: 47. PMID: 28196522
  • Damaj G, Cornillon J, Bouabdallah K, Gressin R, Vigouroux S, Gastinne, T, Ranchon F, Ghésquières H, Salles G, Yakoub-Agha I, Gyan E. Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Bone Marrow Transplant 2017, in press. PMID: 28112752
  • Chantepie SP, Mear JB, Parienti JJ, Bazin A, Benabed K, Chèze S, Gac AC, Johnson-Ansah H, Macro M, Cabrera Q, Reboursiere E, Lancesseur C, Damaj G, Reman O. Blood transfusion in hematologic intensive care unit. Transfusion 2017; 57: 296-302. PMID: 27861958


  • Monnier J, Georgin-Lavialle S, Canioni D, Lhermitte L, Soussan M, Arock M, Bruneau J, Dubreuil P, Bodemer C, Chandesris MO, Lortholary O, Hermine O, Damaj G. Mast cell sarcoma: new cases and literature review. Oncotarget 2016; 7: 66299-66309. PMID: 27602777
  • Reboursiere E, Le Bras F, Herbaux C, Gyan E, Clavert A, Morschhauser F, Malak S, Sibon D, Broussais F, Braun T, Fornecker LM, Garidi R, Tricot S, Houot R, Joly B, Abarah W, Choufi B, Pham AD, Gac AC, Fruchart C, Marin E, Safar V, Parcelier A, Maisonneuve H, Bachy E, Cartron G, Jaccard A, Tournilhac O, Rossi C, Schirmer L, Martignoles JA, Gaulard P, Tilly H, Damaj G, Lymphoma Study Association Lysa Centers. Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study. Oncotarget 2016; 7: 85573-85583. PMID: 27458168
  • Cornet E, Mullier F, Despas N, Jacqmin H, Geara C, Boubaya M, Chatelain B, Troussard X. Evaluation and optimization of the extended information process unit (E-IPU) validation module integrating the sysmex flag systems and the recommendations of the French-speaking cellular hematology group (GFHC). Scand J Clin Lab Invest. 2016; 76: 465-471. PMID: 27347841
  • Coudre C, Alani J, Ritchie W, Marsaud V, Sola B, Cahu J. HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress. Cell Cycle 2016; 15: 2174-2182. PMID: 27340936
  • Bustany S, Bourgeais J, Tchakarska G, Body S, Hérault O, Gouilleux F, Sola B. Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells. Oncotarget 2016; 7: 45214-45224.PMID: 27286258
  • Reboursiere E, Fouques H, Maigne G, Johnson H, Chantepie S, Gac AC, Reman O, Macro M, Benabed K, Troussard X, Damaj G, Chèze S. Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles. Int J Hematol 2016; 104: 85-91. PMID: 27040278
  • Cornet E, Mossafa H, Courel K, Lesesve JF, Troussard X. Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification. BMC Res Notes 2016; 9: 138. PMID: 26935937
  • Chantepie SP, Parienti JJ, Salaun V, Benabed K, Chèze S, Gac AC, Johnson-Ansah H, Macro M, Damaj G, Vilque JP, Reman O. The prognostic value of hematogones in patients with acute myeloid leukemia. Am J Hematol 2016; 91: 566-570. PMID: 26934680
  • Gac AC, Azar N, Daguindau E, Cartron G, Fornecker LM, Gyan E, Broussais-Guillaumot F, Garidi R, Choufi B, Chantepie SP, Béné MC, Guiéze R, Bijou F, Gressin R, Amorim S, Damaj G. Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases. Leuk Lymphoma 2016; 57: 1149-1153. PMID: 26879408

Télécharger la page

Dernière modification : 3 mai 2022

PUBLICATIONS 2012 - 2015

Voir les publications antérieures (pdf - 239 Ko)

Université de Caen Normandie
équipe MICAH
CHU niveau 3 | 5 avenue de la Côte de Nacre | 14032 Caen Cedex 5 | France